These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 11069028
1. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells. Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Burrows C, Hoyle PE, Lee JT, Moye PW, Shelton JG, Franklin R, McCubrey JA. Leukemia; 2000 Nov; 14(11):1921-38. PubMed ID: 11069028 [Abstract] [Full Text] [Related]
10. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK, McCubrey JA. Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369 [Abstract] [Full Text] [Related]
13. Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Kuo WL, Abe M, Rhee J, Eves EM, McCarthy SA, Yan M, Templeton DJ, McMahon M, Rosner MR. Mol Cell Biol; 1996 Apr; 16(4):1458-70. PubMed ID: 8657119 [Abstract] [Full Text] [Related]
14. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, Nelkin BD, Mabry M. J Clin Invest; 1998 Jan 01; 101(1):153-9. PubMed ID: 9421477 [Abstract] [Full Text] [Related]
15. Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells. Kolonics A, Apáti A, Jánossy J, Brózik A, Gáti R, Schaefer A, Magócsi M. Cell Signal; 2001 Oct 01; 13(10):743-54. PubMed ID: 11602185 [Abstract] [Full Text] [Related]
16. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression. Le Gall M, Grall D, Chambard JC, Pouysségur J, Van Obberghen-Schilling E. Oncogene; 1998 Sep 10; 17(10):1271-7. PubMed ID: 9771970 [Abstract] [Full Text] [Related]
17. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells. Shelton JG, Blalock WL, White ER, Steelman LS, McCubrey JA. Cell Cycle; 2004 Apr 10; 3(4):503-12. PubMed ID: 15004527 [Abstract] [Full Text] [Related]
18. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules. Hagiwara S, Iki S, Urabe A, Saeki K, Miwa A, Togawa A, Ozawa K, Takaku F, Yuo A. Int J Hematol; 1998 Dec 10; 68(4):387-401. PubMed ID: 9885438 [Abstract] [Full Text] [Related]
19. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade. Rabenoelina F, Semlali A, Duchesne MJ, Freiss G, Pons M, Badia E. Int J Cancer; 2002 Apr 10; 98(5):698-706. PubMed ID: 11920638 [Abstract] [Full Text] [Related]
20. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade. Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T. Eur J Biochem; 2002 Aug 10; 269(16):3945-57. PubMed ID: 12180971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]